First-in-human study of anticancer immunotherapy drug candidate mobilan: safety, pharmacokinetics and pharmacodynamics in prostate cancer patients.

Autor: Eremina NV; Panacela Labs LLC, Moscow, Russian Federation., Kazey VI; Panacela Labs LLC, Moscow, Russian Federation., Mishugin SV; D.D. Pletnev Municipal Clinical Hospital, Moscow Department of Healthcare, Moscow, Russian Federation., Leonenkov RV; St. Petersburg Clinical Research and Practical Center for Specialized Oncological Medical Care, St. Petersburg, Russian Federation., Pushkar DY; S.I. Spasokukotsky Municipal Clinical Hospital, Moscow Department of Healthcare, Moscow, Russian Federation., Mett VL; Buffalo BioLabs LLC, Buffalo, NY, USA., Gudkov AV; Department of Cell Stress Biology, Roswell Park Comprehensive Cancer Center, Buffalo, NY, USA.

Publikováno v: Oncotarget [Oncotarget] 2020 Apr 07; Vol. 11 (14), pp. 1273-1288. Date of Electronic Publication: 2020 Apr 07 (Print Publication: 2020).

[Predictive value of serum PSA in detection of prostate cancer by fine needle biopsy].

Autor: Pozharisskiĭ KM, Arzumanov AA, Kudaĭbergenova AG, Ovchinnikov IV, Leonenkov RV

Publikováno v: Voprosy onkologii [Vopr Onkol] 2008; Vol. 54 (3), pp. 324-7.